Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis.
Biomarkers
/ blood
Butyrates
/ blood
Endotoxemia
/ blood
Fatty Acids, Volatile
/ blood
Female
Humans
Hypertension, Portal
/ blood
Inflammation
/ blood
Liver
/ metabolism
Liver Cirrhosis
/ blood
Male
Middle Aged
Peritonitis
/ blood
Portasystemic Shunt, Transjugular Intrahepatic
/ methods
Retrospective Studies
SCFAs
cytokines
hemodynamics
liver
Journal
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
pubmed:
28
7
2019
medline:
26
5
2020
entrez:
27
7
2019
Statut:
ppublish
Résumé
Short-chain fatty acids (SCFAs) are gut microbiota-derived products that participate in maintaining the gut barrier integrity and host's immune response. We hypothesize that reduced SCFA levels are associated with systemic inflammation, endotoxemia, and more severe hemodynamic alterations in cirrhosis. Patients with cirrhosis referred for a hepatic venous pressure gradient (HVPG) measurement (
Identifiants
pubmed: 31345057
doi: 10.1096/fj.201901327R
doi:
Substances chimiques
Biomarkers
0
Butyrates
0
Fatty Acids, Volatile
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM